Skip to content
Brand AI

Recombinetics

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2021

    Recombinetics and AstraZeneca announce NF1 research collaboration

    Recombinetics announced a research collaboration with AstraZeneca to assess selumetinib for cutaneous neurofibromas using Surrogen's NF1 preclinical platform.

    Source